Abstract:Osteoclast lineage commitment and differentiation have been studied extensively, although the mechanism by which transcription factor(s) control osteoclast terminal differentiation, activation, and function remains unclear. CCAAT/enhancer-binding protein alpha (C/ebp alpha) has been reported to be a key regulator of osteoclast cell lineage commitment, yet C/ebp alpha's roles in osteoclast terminal differentiation, activation and function, and bone homeostasis, under physiological or pathological conditions, have not been studied because newborn C/ebp alpha-null mice die within several hours after birth. Furthermore, the function of C/ebp alpha in osteoclast terminal differentiation, activation, and function is largely unknown. Herein, we generated and analyzed an osteoclast-specific C/ebp alpha conditional knockout (CKO) mouse model via Ctsk-Cre mice and found that C/ebp alpha-deficient mice exhibited a severe osteopetrosis phenotype due to impaired osteoclast terminal differentiation, activation, and function, including mildly reduced osteoclast number, impaired osteoclast polarization, actin formation, and bone resorption, which demonstrated the novel function of C/ebp alpha in cell function and terminal differentiation. Interestingly, C/ebp alpha deficiency did not affect bone formation or monocyte/macrophage development. Our results further demonstrated that C/ebp alpha deficiency suppressed the expression of osteoclast functional genes, e.g. encoding cathepsin K (Ctsk), Atp6i (Tcirg1), and osteoclast regulator genes, e.g. encoding c-fos (Fos), and nuclear factor of activated T-cells 1 (Nfatc1), while having no effect on Pu.1 (Spi1) expression. Promoter activity mapping and ChIP assay defined the critical cis-regulatory element (CCRE) in the promoter region of Nfatc1, and also showed that the CCREs were directly associated with C/ebp alpha, which enhanced the promoter's activity. The deficiency of C/ebp alpha in osteoclasts completely blocked ovariectomy-induced bone loss, indicating that C/ebp alpha is a promising new target for the treatment of osteolytic diseases. Copyright (C) 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Activating Transcription Factor 4 Regulates Osteoclast Differentiation in Mice

C/Ebp Alpha Regulates Osteoclast Lineage Commitment

TRAF family member-associated NF-κB activator (TANK) induced by RANKL negatively regulates osteoclasts survival and function.

Activating Transcription Factor 4 is Critical for Proliferation and Survival in Primary Bone Marrow Stromal Cells and Calvarial Osteoblasts

A Specific Osteogenic Transcription Factor - Activating Transcription Factor 4(ATF4)

Reduced Osteoblast Activity in the Mice Lacking TR4 Nuclear Receptor Leads to Osteoporosis

RhoA Promotes Osteoclastogenesis and Regulates Bone Remodeling Through Mtor-Nfatc1 Signaling.

The molecular understanding of osteoclast differentiation

CTLA4-Ig Directly Inhibits Osteoclastogenesis by Interfering With Intracellular Calcium Oscillations in Bone Marrow Macrophages

Ctrp4, a New Adipokine, Promotes the Differentiation of Osteoblasts.

Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos

ATF3 controls proliferation of osteoclast precursor and bone remodeling

Parathyroid Hormone Increases Activating Transcription Factor 4 Expression and Activity in Osteoblasts: Requirement for Osteocalcin Gene Expression.

C/Ebp Alpha Controls Osteoclast Terminal Differentiation, Activation, Function, And Postnatal Bone Homeostasis Through Direct Regulation Of Nfatc1

MicroRNA-34c Promotes Osteoclast Differentiation Through Targeting LGR4

Receptor activator of nuclear factor-kappaB ligand-induced nuclear factor of activated T cells (C1) autoregulates its own expression in osteoclasts and mediates the up-regulation of tartrate-resistant acid phosphatase

FOXO1 Mediates RANKL-induced Osteoclast Formation and Activity.

Interleukin‐4 Inhibits RANKL‐induced NFATc1 Expression Via STAT6: A Novel Mechanism Mediating Its Blockade of Osteoclastogenesis

Experimental study of the metal-regulatory transcription factor-1 on osteoclast differentiation and function

Adipocytes Enhance Expression of Osteoclast Adhesion-Related Molecules Through the Cxcl12/Cxcr4 Signalling Pathway

Mir-214 Targets Atf4 to Inhibit Bone Formation